Blumenfeld, Andrew M.
Knievel, Kerry
Manack Adams, Aubrey
Severt, Lawrence
Butler, Matthew
Lai, Hongxin
Dodick, David W.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials
https://doi.org/10.1007/s12325-021-01923-3
Documents that mention this clinical trial
Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials
https://doi.org/10.1007/s12325-021-01923-3
Documents that mention this clinical trial
Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials
https://doi.org/10.1007/s12325-021-01923-3
Funding for this research was provided by:
AbbVie
Article History
Received: 7 July 2021
Accepted: 14 September 2021
First Online: 7 December 2021